Franco Negron of Simtra Biopharma Solutions shares insight on the sterile liquids manufacturing space.

As 2026 approaches, the clinical research and development landscape is evolving beyond traditional scientific innovation with ...

Jubilant Therapeutics Inc., a clinical-stage biopharmaceutical company, has appointed Daniel J. O'Connor as President & Chief ...

Natera Inc., a cell-free DNA and precision medicine company, has acquired Foresight Diagnostics, a leader in ultrasensitive ...

The FDA has approved BMS’ Breyanzi (lisocabtagene maraleucel; liso-cel), a CD19-directed CAR T cell therapy, for adults with ...

Neurimmune has expanded its transthyretin amyloid cardiomyopathy (ATTR-CM) collaboration with Alexion, an AstraZeneca company ...

Add capabilities in Europe and the U.S. for enhanced third-party logistics to support specialty pharmaceuticals.

Vetter, a globally leading CDMO, announced the retirement of its Managing Director, Thomas Otto, after over 35 years at the ...

CDMOs have become structural pillars of drug development, keeping pipelines moving, absorbing operational shocks, and turning ...

Thermo Fisher Scientific is expanding its bioprocessing capabilities across Asia with a new Bioprocess Design Center in ...

Designed to improve analytical capabilities by separating particles prior to analysis, enabling high-resolution ...

System features “card-to-card” technology with cardboard blister and backing comprised of the same material.